Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis.
Year: 2011
Type: article
Study design: Observational Study
Source: PubMed
Authors: S R Greisen, H J Moller, K Stengaard-Pedersen, M L Hetland, K Hørslev-Petersen, A Jørgensen, M Hvid, B Deleuran
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W69356324
